Fintel reports that on May 29, 2025, Goldman Sachs initiated coverage of BioNTech SE - Depositary Receipt () (NasdaqGS:BNTX) ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

which is safe and efficient for many people in all the world Pfizer Uruguay and BioNTech SE said in a release that Uruguay will be receiving 2,700,00 doses of the BNT162b2 vaccine, based on ARNm ...

Investors remained risk-averse on prospects of escalation in Israel's attack on Gaza in the wake of the Hamas attacks Moderna is suing Pfizer and its German partner BioNTech for patent ...

Now, Pfizer and BioNTech are joining forces to try to grab a slice of the market. Having already brought their mRNA-based COVID-19 vaccine Comirnaty to market at breakneck speed, Pfizer and ...

Access BioNTech stock price history with daily data, historical prices, all-time highs, and stock chart history. Download and analyze trends easily.

Rocketing to a price of $106.75 during today's morning trading session, shares of BioNTech SE are still -23.88% below their average target price of $140.24. Could there be more upside potential for ...

European regulators questioned the integrity of early batches of Pfizer/BioNTech’s mRNA vaccine, although the matter was resolved before approval, according to information leaked online ...

Join us for a quick overview of BioNTech SE, a Biotechnology company whose shares moved 0.3% today. Here are some facts about the stock that should help you see the bigger picture: BioNTech SE has ...